Orchard Therapeutics Plc's ability to collect accounts receivable sequentially worsen to 3.61, indicating more challenging environment then in the second quarter 2023, but still, it is a far cry from any concerns. Orchard Therapeutics Plc's Accounts Receivable average collection period in the Sep 30 2023 quarter, has increased to 101 days, from 95 days, in the Jun 30 2023 quarter.

If we take a look into Healthcare sector 516 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2023 from 3302 to 3308.

What is Receivable Turnover Ratio?
What is Orchard Therapeutics Plc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ORTX Receivables Turnover Ratio	(Sep 30 2023) III. Quarter	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter
Y / Y Receivable Change	46.16 %	131.22 %	-	472.09 %	294.5 %
Y / Y Revenue Change	9.09 %	67.45 %	-77.61 %	1346.38 %	384.65 %
Receivable Turnover Ratio (TTM)	3.61	3.83	4.37	4.33	4.63
ORTX's Total Ranking	# 3308	# 3302	# 3202	# 3218	# 3202
Accounts Receivable average collection period days	101	95	84	84	79
Seq. Receivable Change	-35.19 %	-	-	100.02 %	2.52 %
Seq. Revenue Change	-13.84 %	491.27 %	-82.29 %	20.93 %	32.26 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 48
Healthcare Sector	# 517
Overall Market	# 3308

Receivable Turnover Ratio Statistics
High	Average	Low
0.1	0.07	0.01
(Sep 30 2023)		(Dec 31 2018)

ORTX Company Profile • Back to ORTX Efficiency Comparisons • Compare ORTX Receivables Turnover Ratio to its Competitors

Financial Statements
Orchard Therapeutics Plc's Accounts Receivable	$ 6 Millions	Visit ORTX's Balance sheet
Orchard Therapeutics Plc's Sales TTM	$ 22 Millions	Visit ORTX's Income Statement
Sources of ORTX's Revenues		Visit ORTX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ORTX's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ORTX's Growth Rates	ORTX's Roa	ORTX's Inventory Turnover Ratio	ORTX's Dividend Comparisons
ORTX's Profitability Ratios	ORTX's Roi	ORTX's Asset Turnover Ratio	ORTX's Dividend Growth
ORTX's Valuation Ratios	ORTX's Roe	ORTX's Financial Strength Ratios	ORTX's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2023	Receivable at quarter ending Sep 30 2023
Arbutus Biopharma Corp	9.56	$ 22.241 Millions	$ 2.325 Millions
Quidelortho Corp	9.56	$ 3,121.741 Millions	$ 326.650 Millions
The Pennant Group Inc	9.49	$ 523.602 Millions	$ 55.171 Millions
Femasys Inc	9.49	$ 1.093 Millions	$ 0.115 Millions
Irhythm Holdings Inc	9.40	$ 471.752 Millions	$ 50.163 Millions
Ngm Biopharmaceuticals Inc	9.37	$ 22.433 Millions	$ 2.393 Millions
Biolase Inc	9.36	$ 49.382 Millions	$ 5.276 Millions
Procyon Corporation	9.24	$ 4.684 Millions	$ 0.507 Millions
Tvardi Therapeutics Inc	9.20	$ 21.225 Millions	$ 2.308 Millions
Acorda Therapeutics Inc	9.18	$ 111.118 Millions	$ 12.106 Millions
Harmony Biosciences Holdings inc	9.09	$ 541.622 Millions	$ 59.598 Millions
Myomo Inc	9.08	$ 17.258 Millions	$ 1.901 Millions
Igc Pharma Inc	9.04	$ 1.343 Millions	$ 0.149 Millions
Talis Biomedical Corporation	9.04	$ 2.196 Millions	$ 0.243 Millions
Emmaus Life Sciences Inc	8.94	$ 28.460 Millions	$ 3.185 Millions
Inspire Medical Systems inc	8.90	$ 569.809 Millions	$ 63.988 Millions
Avid Bioservices Inc	8.90	$ 139.466 Millions	$ 15.678 Millions
Biodesix Inc	8.87	$ 44.026 Millions	$ 4.966 Millions
Sanara Medtech Inc	8.83	$ 61.677 Millions	$ 6.987 Millions
Insmed Inc	8.76	$ 277.639 Millions	$ 31.691 Millions
Scientific Industries Inc	8.74	$ 11.043 Millions	$ 1.264 Millions
Arcturus Therapeutics Holdings Inc	8.70	$ 296.237 Millions	$ 34.067 Millions
Immucell Corporation	8.69	$ 15.668 Millions	$ 1.803 Millions
Addus Homecare Corp	8.64	$ 1,028.360 Millions	$ 119.076 Millions
Adapthealth Corp	8.62	$ 3,122.226 Millions	$ 362.205 Millions
Celldex Therapeutics inc	8.60	$ 4.365 Millions	$ 0.508 Millions
Zymeworks Inc	8.53	$ 461.579 Millions	$ 54.102 Millions
Henry Schein Inc	8.53	$ 12,693.000 Millions	$ 1,488.250 Millions
Acadia Healthcare Company Inc	8.49	$ 2,923.743 Millions	$ 344.337 Millions
Adma Biologics Inc	8.48	$ 233.238 Millions	$ 27.518 Millions

Date modified: 2026-06-23T20:00:26+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.